METHODS This is a retrospective study evaluating the minimum detection cancers in the group of women mammographically examined in our department. The study covers the period from 1. 1. 2012 to 31. 12. 2012. Interestingly we introduced several interesting case studies. OBJECTIVE 1. Confirmation upward trend in the number of minimal breast cancers, stage T1. 2. The need for multidisciplinary cooperation for quick minimal surgical intervention and effective cancer treatment. METHODS Department of Radiology, Department of Gynecology and Obstetrics, Third Faculty of Medicine Charles University, Faculty Hospital KV, Prague. METHODS The methodology is based on a retrospective evaluation of the number of participants, regardless of age, that come for examination the workplace Breast Radiologists in 2012. Of all the tests are then evaluated the number and types of histological proven cancer, focusing on cancer detection stage T1 and other solutions from surgery after cancer treatment. RESULTS In 2012 it was made in 6700 FNKV screening mammography, of this number, 45 were confirmed malignant tumors in asymptomatic women. In 2012 it was simultaneously performed 2276 diagnostic mammography in women with clinically palpable resistance, and malignant tumors was confirmed in 122 women. Overall, mammographically and ultrasonographically examined 10 146 women for the year 2012. Of the 167 women with histologically confirmed malignant tumor. Brest carcinoma, stage T1, was diagnosed in 34% of patients and 66% of patients were malignant bearing greater than 10mm. The most common histological type of breast cancer in our department during the period from 1. 1. 2012 to 31. 12. 2012 was invasive ductal carcinoma (DIC) and in 82% of invasive lobular carcinoma (LIC) was diagnosed in 10%, mixed DIC and LIC in 4% and other cancers represented 4%. CONCLUSIONS The diagnosis mode, core cut biopsy with histological conclusion, preoperative marking bearings in the presence of the surgeon, assessment resection, definitive histology, mammary team, cancer treatment, subsequent postoperative control at one workplace, is in terms of the patient not only effective, individualized and complex, but also cost effective.